Access to Medicines
More about the ongoing talks at WTO to increase access to essential medicines, especially in developing countries.
Please find all related articles below.
Elżbieta Bieńkowska (born on 4 February 1964 in Katowice, Poland) became the Minister of Regional Development in the Cabinet of the Prime Minister Donald Tusk between 2007 and 2013 in Poland. She was then appointed a Deputy Prime Minister and carried out her mandate at the Ministry of Infrastructure and Development. In 2014 she has been nominated by the Polish government for European Commissioner who has received the Internal Market, Industry, Entrepreneurship and SMEs portfolio (...)
From 1 November 2014, Cecilia Malmström will take office as the new Commissioner for Trade, under the Juncker Commission. The appointment of Swedish native Ms. Malmstrom implies that the President-elect of the European Commission, Jean-Claude Juncker, would like to further promote discussion with the U.S. on the much debated Transatlantic Trade and Investment Partnership (TTIP).
By Leonardo Palumbo, EPHA Policy Coordinator for EU Affairs and Arthur Matthews, Policy Assistant
Frans Timmermans has been officially designated to be one of the six Vice-Presidents and the First Vice-President in charge of Better Regulation, Inter-Institutional Relations, the Rule of Law and the Charter of Fundamental Rights – a newly installed Directorate General.
By Dorota Sienkiewicz, EPHA Health Equity and Policy Coherence Coordinator
Putting in place this brand new DG reflects the EU’s new strategy to focus on areas where it can make a difference (in its own (...)
After months of inaction and neglect from the international community, the Ebola epidemic in west Africa has now spiralled utterly out of control. Today, the virus is a threat not only to the countries where the outbreak has overwhelmed the capacity of national health systems, but also to the entire world.
We urge our governments to mobilise all possible resources to assist west Africa in controlling this horrific epidemic. Based on our (...)
A study in Germany, France and the Netherlands highlights an alarming trend: the majority of medicines granted marketing authorisation has no added therapeutic value (ATV) compared to medicines already on the market. In some cases the new medicine even did more harm than good. These are the results of a research conducted by Wemos and EPHA. The figures are based on evaluations of several international drug bulletins.
1st October 2014, Brussels - The French drug bulletin La Revue Prescrire (...)
The president of the European Parliament has called for a "satisfactory response" from Mr Juncker before the commissioner hearings begin. MEPs from several political groups and the Belgian Minister of Health joined the public health community in calling for medicinal products and health technology to be moved back in to the health portfolio of the European Commission. This adds to the voices of European and global players representing various branches of healthcare that expressed concerns (...)
Brussels, 16 September 2014 - We are writing to express our astonishment and concern regarding your decision to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of internal market and industry within the new Commission.
Dear Mr Jean-Claude Juncker, President-elect of the European Commission,
The economic crisis, the ageing of the population, technological advances, and new health threats, including (...)
12 September 2014, Brussels – The public health community has reacted with alarm and disbelief at the ill-thought distribution of responsibilities amongst the in-coming European Commissioners.
In an announcement on Wednesday 10 September, the President-elect (1) revealed that health technology and pharmaceutical policy is being moved from the Health and Food Safety Commissioner to the new Commissioner for Internal Market, Industry, Entrepreneurship and SMEs (2). The European Public (...)
Brussels, 5 September – Over the last two days, the European Public Health Alliance (EPHA) held its two-day annual conference entitled “Tectonic tensions – wealthy Europe’s fear of commitment”. The event brought together more than 30 speakers (1) from across Europe’s health professions, governments, the European Commission, civil society and an audience of more than 200 people.
The conference addressed the future of public health in Europe just before (...)
Trade and Health
poverty and health
social determinants of health
EPHA 5th Annual Conference
Brussels, 4 September – Today EPHA’s Annual Conference entitled “Tectonic tensions – wealthy Europe’s fear of commitment” held the first of its two-day series of debates on the health priorities of the EU for the next five years. The outgoing Commissioner for Health, the former Lithuanian Health Minister and the Latvian Greek, and Portuguese Secretaries of State for Health, along with an audience of 200 people, engaged in a constructive debate just before (...)